azasetron has been researched along with Hearing Loss, Sensorineural in 1 studies
azasetron: a selective 5-HT3 receptor antagonist; structure given in first source;
Hearing Loss, Sensorineural: Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.
Excerpt | Relevance | Reference |
---|---|---|
"SENS-401 (R-azasetron besylate) is effective against severe acoustic trauma-induced hearing loss." | 3.91 | SENS-401 Effectively Reduces Severe Acoustic Trauma-Induced Hearing Loss in Male Rats With Twice Daily Administration Delayed up to 96 hours. ( Broussy, A; Dyhrfjeld-Johnsen, J; Petremann, M; Poli, S; Romanet, C; Van Ba, CT, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Petremann, M | 1 |
Romanet, C | 1 |
Broussy, A | 1 |
Van Ba, CT | 1 |
Poli, S | 1 |
Dyhrfjeld-Johnsen, J | 1 |
1 other study available for azasetron and Hearing Loss, Sensorineural
Article | Year |
---|---|
SENS-401 Effectively Reduces Severe Acoustic Trauma-Induced Hearing Loss in Male Rats With Twice Daily Administration Delayed up to 96 hours.
Topics: Acoustic Stimulation; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; Evoked Potentials | 2019 |